ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

FDA Designates Zometa For Priority Review.

November 30, 2001

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

Coalition Agrees On Method To Coordinate Issues

March 21, 1980

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

In Brief: Kerman New President Of ACCC, David Johnson Names President Elect; Wyder Gets NY Award

March 20, 1981